课题基金 / 基金详情

Molecular analysis of compensatory mechanism which tumor cells exert in VEGF deficent/RipTag mouse

Molecular analysis of compensatory mechanism which tumor cells exert in VEGF deficent/RipTag mouse
VEGF缺陷/RipTag小鼠肿瘤细胞代偿机制的分子分析
批准号:
15590363
负责人:
INOUE Masahiro
金额:
$1.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

INOUE Masahiro的其他基金

相似基金

相关文献

中文摘要
翻译
虽然我们从加州大学旧金山分校转移了RipTag小鼠,但我们发现日本的肿瘤形成显著减少。已知RipTag小鼠肿瘤的形成对遗传背景敏感。虽然我们试图通过将其回交到C57B1/6N或DBA背景中来解决问题,但我们没有观察到显著的肿瘤形成恢复。后来发现,在加州大学旧金山分校的原始小鼠群体中也观察到了同样的现象。RipTag小鼠的基因组可能发生了一些变化。目前正在考虑重新建立转基因小鼠。同时,对RipTag/VEGF-/-小鼠的存档胰腺标本进行分析,发现有残留的肿瘤,微血管密度很低,没有明显的坏死。我们发现残留的肿瘤含有广泛的缺氧区。这一发现表明,抑制血管生成会导致缺氧区的出现,并减少肿瘤的形成。在这些低氧肿瘤中,凋亡并没有明显增加,肿瘤细胞似乎是通过适应低氧微环境而存活下来的。从临床角度看,抗血管生成治疗可能通过选择耐低氧癌细胞来诱导耐药。于是,我们开始研究肿瘤细胞耐缺氧的分子机制。我们发现,不同的细胞系可以在低氧条件下维持几周。这些肿瘤细胞是活的,但没有观察到增殖和细胞死亡。我们重点研究了mTOR信号转导通路,它在低氧条件下被抑制,但其后果尚不清楚。我们发现,抑制mTOR信号对它们在长期低氧条件下的生存至关重要。
英文摘要
While we transferred RipTag mice from university of California at San Francisco, we found profound reduction of tumor formation in Japan. Formation of tumor in RipTag mouse is known to be sensitive to the genetic background. Although we tried to resolve the problem by backcrossing it into C57B1/6N or DBA background, we did not observe remarkable recovery of tumor formation. Afterwards, it has been revealed that the same phenomenon was observed in the original mouse colony in UCSF. It is likely that some genomic change in RipTag mouse occurred. Re-establishment of the transgenic mouse is now under consideration. Meanwhile, analysis of the archive pancreas samples from RipTag/VEGF-/- mice revealed that there were residual tumors with quite low microvessel density without apparent necrosis. We found that the residual tumors contains broad hypoxic region. This finding suggests that inhibiting angiogenesis results in emergence of hypoxic region as well as reduction of tumor formation. In these hypoxic tumors, apoptosis was not significantly increased, tumor cells seems to survive by adapting to the hypoxic microenvironment. From clinical point of view, the results offered a serious issue that anti-angiogenesis therapy might induce drug resistance by selecting hypoxia tolerant cancer cells. Then, We started to investigate the molecular mechanism of hypoxia tolerance of malignant cells. We found various cell lines can be maintained in hypoxic conditions for a couple of weeks. These tumor cells were alive but no proliferation nor cell death was observed. We focused on the mTOR signaling, which is know to be suppressed in hypoxia, but the consequence has not been clarified yet. We revealed that suppression of mTOR signaling is critical for their survival under prolonged hypoxic conditions.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
Targeting hypoxic cancer cells with a protein prodrug is effective in experimental malignant ascites.
用蛋白质前药靶向缺氧癌细胞对于实验性恶性腹水是有效的。
DOI: --
发表时间: 2004
期刊: Int J Oncol 25
影响因子: --
作者: [Inoue, M., et al.]
通讯作者: et al.
Cyclic phosphatidic acid inhibits RhoA-mediated autophosphorylation of FAK at Tyr-397 and subsequent tumor-cell invasion
环磷脂酸抑制 RhoA 介导的 Tyr-397 处 FAK 自身磷酸化和随后的肿瘤细胞侵袭
DOI: --
发表时间: 2003
期刊: Int. J. Oncology 22
影响因子: --
作者: [R.Ishihara, M.Tatsuta, H.Iishi, M.Baba, N.Ucdo, K.Higashino, M.Mukai, S.Ishiguro, S.Kobayashi, K.Murakami-Murofushi, 向井睦子]
通讯作者: 向井睦子
DOI: 10.1172/jci200422087
发表时间: 2004-09-01
期刊: JOURNAL OF CLINICAL INVESTIGATION
影响因子: 15.9
作者: [Giraudo, E, Inoue, M, Hanahan, D]
通讯作者: Hanahan, D
Hoffman, J., Giraudo, E., Singh, M., Inoue, M et al.: "Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma."Cancer Cell. 4. 383-391 (2003)
Hoffman, J.、Giraudo, E.、Singh, M.、Inoue, M 等人:“鳞状细胞癌转基因小鼠模型中的进行性血管变化。”癌症细胞。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    Roe of polarity switching of cancer cell clusters in metastasis
    • 批准号:
      18H02648
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.98万
    • 财政年份:
      2018
    • 负责人:
      INOUE Masahiro
    • 依托单位:
    Malignant conversion of cancer cells by disruption and remodeling of cancer cell-clusters in newly developed primary culture system
    Identification and characterization of novel kinase, AKB14-3-3-1, which is a possible target of sleeping sickness.
    • 批准号:
      23590500
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      INOUE Masahiro
    • 依托单位:
    Development of Stretchable Conductive Inks for Advanced Human/machine Interfaces
    国内基金
    海外基金
    基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
    • 批准号:
      2026JJ80680
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      姜平
    • 依托单位:
    协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
    • 批准号:
      JCZRLH202601503
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
    • 批准号:
      2026JJ80684
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚攀
    • 依托单位: